Infection and Drug Resistance (Mar 2023)

Successful Treatment of Rare Pulmonary Coprinopsis cinerea Infection in a 17-Year-Old Female After Hematopoietic Stem Cell Transplantation: A Case Report

  • Yu U,
  • Cao K,
  • Yang C,
  • Wang C,
  • Li Y,
  • Zhou X,
  • Zhang Q,
  • Wang Y,
  • Wen F,
  • Liu S,
  • Wang X

Journal volume & issue
Vol. Volume 16
pp. 1567 – 1572

Abstract

Read online

Uet Yu,1 Ke Cao,2 Chunlan Yang,1 Chunjing Wang,1 Yue Li,1 Xiaohui Zhou,1 Qian Zhang,1 Yuanxiang Wang,3 Feiqiu Wen,1 Sixi Liu,1 Xiaodong Wang1 1Department of Hematology and Oncology, Shenzhen Children’s Hospital, Shenzhen, People’s Republic of China; 2Department of Laboratory Medicine, Shenzhen Children’s Hospital, Shenzhen, People’s Republic of China; 3Department of Cardiothoracic Surgery, Shenzhen Children’s Hospital, Shenzhen, People’s Republic of ChinaCorrespondence: Xiaodong Wang; Sixi Liu, Email [email protected]; [email protected]: Invasive fungal infections (IFIs) are among the most severe complications in recipients of hematopoietic stem cell transplantation (HSCT) recipients and in patients with hematological malignancies. An increasing number of uncommon fungal infections have been reported in this era of antifungal prophylaxis. Coprinopsis cinerea is a rare pathogen that causes opportunistic infections in the immunocompromised patients, including HSCT recipients and is associated with very high mortality rates. Herein, we present a successfully treated pediatric HSCT patient with breakthrough pulmonary IFI caused by Coprinopsis cinerea despite posaconazole, prophylaxis using multidisciplinary approaches.Keywords: Coprinopsis cinerea, Hormographiella aspergillata, invasive fungal infection, hematopoietic stem cell transplantation, leukemia, case report

Keywords